Dutch Symposium: ZonMw Lectures (Komaroff, Van Elzakker, Frankovich, Bergquist)

Pyrrhus

Senior Member
Messages
2,913
Likes
8,514
Location
U.S., Earth
ZonMw Symposium
November 19th 14:30 - 18:00 | UPDATE ON INTERNATIONAL ME / CFS RESEARCH
Anthony Komaroff, Michael van Elzakker, Jennifer Frankovich & Jonas Bergquist

____________________________________________________________

Click on this link, and then click the "play" button at bottom of the page:

http://www.blendedconnect.nl/events/zonmw/

Note: The video starts off in Dutch, but the English presentations begin at 22:17 minutes.
_____________________________________________________________
 
Last edited:

ljimbo423

Senior Member
Messages
4,333
Likes
11,427
Location
United States, New Hampshire
Anthony Komaroff presents this slide at 38:00. Which I find really interesting. Because for several years I've thought Gut Dysbiosis is causing my ME/CFS and neuroinflammation. (number 8)

It's good to see someone like Anthony Komaroff thinks gut dysbiosis could be causing chronic neuroinflammation in ME/CFS too.

At 38:40- Anthony Komaroff says- "Dysbiosis, involving the microbiome of the gut, that possibly is a chronic stimulus to neuroinflammation".

I just watched a video you posted from Michael VanElzakker, PhD (Here). At 7:32 he talks about how the vagus nerve could sense inflammatory bacteria in the gut and cause a "Central illness response" in the brain.


1606432837613.png
 
Last edited:

raghav

Senior Member
Messages
806
Likes
1,851
Location
India
Can you explain more? Ard they giving patients B6?
In the Q&A at 1:32:00 Berquist answers to a question regarding the trials. He says they are uncertain even whether they will be able to start by March 2021. He says funding is also an issue. He explains about the kynurenine trials at 1:19:00 where he has given a flowchart of the kynurenine pathway and the hypothesis. But there is no mention of B6.
 

raghav

Senior Member
Messages
806
Likes
1,851
Location
India
Berquist said the number of participants for the trial has been reduced and only a pilot trial is going to be conducted. Maybe due to shortage of funds ?.